Ryvu Therapeutics SA (RVU) — Long-term Investment Intensity
Ryvu Therapeutics SA (RVU) has a Long-term Investment Intensity of 0.0% as of September 2022. Long-term investments of zł21.60 represent 0.0% of total assets of zł169.84 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check RVU total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ryvu Therapeutics SA Long-term Investment Intensity (2017–2021)
This chart shows how Ryvu Therapeutics SA's Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2021. As of September 2022, the intensity stands at 0.0%, reflecting long-term investments of zł21.60 against total assets of zł169.84 Million PLN. Explore how well can Ryvu Therapeutics SA service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Ryvu Therapeutics SA (2017–2021)
The table below presents the year-by-year Long-term Investment Intensity for Ryvu Therapeutics SA from 2017 to 2021, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Ryvu Therapeutics SA (RVU) market capitalisation.
| Year | LT Investment Intensity | LT Investments (PLN) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.0% | zł29.40 | zł228.81 Million | ▲ +0.0 pp |
| 2020 | 0.0% | zł29.12 | zł295.64 Million | ▼ 0.0 pp |
| 2019 | 0.0% | zł23.75 | zł182.89 Million | ▲ +0.0 pp |
| 2017 | 0.0% | zł2.04 | zł103.57 Million | — |